Newsroom
January 13, 2010
…University Makes a Difference” • Jim Poage, CEO and president of the San Antonio Technology Accelerator Initiative; “Kiss More Frogs, Raise More Money” Moderated by: • John Cole, Ph.D., interim…
January 7, 2010
…with chronic kidney disease secondary to diabetes ultimately need dialysis or kidney transplants, in part because many die of cardiovascular causes before reaching end-stage renal disease. As a result, it…
December 17, 2009
…onto the lining of a nerve in the nose. The goal is to prevent the death of brain cells after stroke. The drugs are delivered via the olfactory nerve, which…
December 9, 2009
…the body after chemotherapy. The tumor’s growth is halted because these agents deprive the cancer of the estrogen it needs to grow. For women with certain types of breast cancer,…
December 7, 2009
…the United States.” Collaborator David Wampler, Ph.D., assistant professor of emergency health sciences, said: “If a patient is having chest pain, there is a cause for it, myocardial infarction (MI)…
November 13, 2009
…a paid spokesman for Novartis, one of the world’s largest pharmaceutical companies. Novartis makes two of the leading drugs to treat CML, imatinib (sold as Gleevec) and nilotinib (sold as…